DPT Dispensing Form1

Stage 1: Prescription Check

Diagnosis 2: depression

1. Review Patient details, identify the missing information if any:

patient's name and registration ID, date , signature of doctor and pharmacist.

2. Review the Rx, identify the missing information if any:

The duration to take medication

Stage 2: Medication(s) Information

3. Medication Name 3: fluoxetine

3.1. Mention maximum 3 Trade Names (available in Oman)

Prozac
a.
rapiflux
b.

c. Sarafem

3.2. Class (pharmacological group)

selective serotonin reuptake inhibitor

3.3. MoAs
blocking the reuptake of serotonin into presynaptic serotonin neurons by blocking the reuptake transporter protein located in
the presynaptic terminal.

3.4. Indication in this Rx

Antidepressant

3.5. Adult dose in this Rx

20-60mg dividing during a day

1 Instruction for students: use this form to dispense every case in this course as per the lecturer’s instructions.
2 Do not use abbreviations
3 Stage 2 to be used as many as required for each medicine in a case prescription.

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 3.6. Paediatric dose in this Rx

10-20 mg a day
3.7. Other Indication(s):

Obsessive-compulsive disorder

3.8. Common side effects (BNF)

Chill, feeling abnormal, uterine disorder ,vasodilation, blurred vision

3.9. Monitoring measure for the common SEs

3.10. Side Effects (important five)

Insomnia

a.
Decreased appetite1
b.
Headache
c.
Dizziness
d.
Diarrhoea Nausea
e.

3.11. Toxicity range:

Up to 1500mg

3.12. Antidote or the recommended management of toxicity:

Activated charcoal, which may be used with sorbitol, may be as or more effective than emesis or lavage

3.13. Contraindication/warning

a. Contraindication
Hypersensitivity , non-selective monoamine oxidase inhibitors, metoprolol used in cardiac failure

b. Caution/Precaution (relate it to the case)

In patients with diabetes, treatment with an SSRI may alter glycaemic control.
Weight loss may occur in patients taking fluoxetine but it is usually proportional to baseline body weight.
Withdrawal symptoms when treatment is discontinued are common, particularly if discontinuation is abrupt

c. Pregnancy category and recommendation (with ref):

should not be used during pregnancy unless the clinical condition of the woman requires treatment with fluoxetine and justifies the
potential risk to the foetus.

d. Breast feeding and recommendation (with ref):

Not recommended

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 4. Medication(s) related patient’s counselling:

a.

b.

c.

d.

Stage 2: Medication(s) Information

5. Medication Name 4:

Quetiapine

5.1. Mention maximum 3 Trade Names (available in Oman)

Seroquel
d.
SEROquel XR
e.
SEROquel
f.

5.2. Class (pharmacological group)

atypical antipsychotics.

5.3. MoAs
involve rapid dissociation from D2 receptors. [/caption] PET studies show that there is a relationship between D2
receptor occupancy and antipsychotic effects [1]. D2 receptor occupancy in the ranges of 60 % to 75% is associated with
antipsychotic efficacy.

5.4. Indication in this Rx

for the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder

5.5. Adult dose in this Rx

100mg once daily at bed time

5.6. Paediatric dose in this Rx
Not recommended
5.7. Other Indication(s):

Treatment of bipolar disorder, for the treatment of moderate to severe manic episodes in bipolar disorder

5.8. Common side effects (BNF)

Increase appetite, dyspepsia, headache, fever

5.9. Monitoring measure for the common Ses

4 Stage 2 to be used as many as required for each medicine in a case prescription.

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 Paracetamole

5.10. Side Effects (important five)

Decreased haemoglobin

f.
Dizziness
g.
Mild asthenia
h.
Abnormal dreams and nightmares
i.
Seizure
j.

5.11. Toxicity range:

More than800mg a day

5.12. Antidote or the recommended management of toxicity:

Treat the symptom maintaining a patent airway, ensuring adequate oxygenation and ventilation, and monitoring and support of the
cardiovascular system

5.13. Contraindication/warning
Hypersensitivity , cytochrome P450 3A4 inhibitors, such as HIV-protease inhibitors, azole-antifungal agents, erythromycin, clarithromycin
and nefazodone, is contraindicated

e. Caution/Precaution (relate it to the case)

Given the observed risk for worsening of their metabolic profile, including changes in weight, blood glucose (see hyperglycaemia) and
lipids
It cause sedation , take it before bedtime
Acute withdrawal symptoms such as insomnia, nausea, headache, diarrhoea, vomiting, dizziness and irritability have been described after
abrupt cessation of quetiapine. Gradual withdrawal over a period of at least one to two weeks is advisable

f. Pregnancy category and recommendation (with ref):

Only if potential benefit outweigh risk

g. Breast feeding and recommendation (with ref):

Not recommended

6. Medication(s) related patient’s counselling:

e.

f.

g.

h.

Stage 2: Medication(s) Information

7. Medication Name 5:

Haloperidol

7.1. Mention maximum 3 Trade Names (available in Oman)

5 Stage 2 to be used as many as required for each medicine in a case prescription.

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 g. Haldol,

h. Haldol Decanoate

i. Peridol.

7.2. Class (pharmacological group)

Antipsychotics, 1st Generatio

7.3. MoAs

first-generation (typical antipsychotic) which exerts its antipsychotic action by blocking

dopamine D2 receptors in the brain. When 72% of dopamine receptors are blocked, this
drug achieves its maximal effect.

7.4. Indication in this Rx

Treatment of moderate to severe manic episodes associated with bipolar I disorder.

7.5. Adult dose in this Rx

•2 to 10 mg/day orally

7.6. Paediatric dose in this Rx

0.5 to 3 mg/day
7.7. Other Indication(s):

Treatment of schizophrenia and schizoaffective disorder.

7.8. Common side effects (BNF)

Agitation ,Insomnia, Headache,

7.9. Monitoring measure for the common Se

Take rest and at bedtime

7.10. Side Effects (important five)

Dizziness

k.
Visual disturbance
l.
Orthostatic hypotension
m.
Constipation
n.
Vomiting
o.

7.11. Toxicity range:

1mg per kg

7.12. Antidote or the recommended management of toxicity:

bromocriptine or ropinirole

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 7.13. Contraindication/warning
Hypersensitivity , Parkinson's disease , Recent acute myocardial infarction. , Uncompensated heart failure.
History of ventricular arrhythmia or torsades de pointes. Uncorrected hypokalaemia.

h. Caution/Precaution (relate it to the case)

It has been reported that seizures can be triggered by haloperidol

It is recommended that haloperidol is not used alone in patients in whom depression is predominant. It may be
combined with antidepressants to treat those conditions in which depression and psychosis coexist

i. Pregnancy category and recommendation (with ref):

it is recommended that newborn infants be monitored carefully.

j. Breast feeding and recommendation (with ref):

decision must be made whether to discontinue breastfeeding or to discontinue haloperidol therapy taking into
account the benefit of breastfeeding for the child and the benefit of therapy for the woman.

8. Medication(s) related patient’s counselling:

i.

j.

k.

l.

Stage 3: Clinical review

9. Intervention

Doctor prescribed quetiapine

10. Pharmacist’s recommendations to doctor on therapy monitoring:

Cancel this medication because it will increase the risk of irregular heart rhythm

11. Counselling:
a. Rx dispensing

b. Health advices

Do your best to stay active every day

Try to keep up with friends
Seek out support from your friend and family

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.

 12. Instructions for patient on follow-up

Visit your doctor to control your condition

Stage 4: Dispensing of Rx
13. Pharmaceutical Calculation

Fluoxeitine 1*30 = 30 tablet

14. Patient Medicine Label 6,7

Patient Name: Qais said alalwi ID: 55391

DATE: 2-11-2020 Quantity: 30 tablet
Medicine Name: Fluoxeitine 20 mg

Take one tablet once a day for 1 month

Icrease after 3-4 weeks if necessary

Reference number: 543213 Expiry date: 1-11-2021 Batch NO: 54

Name of institution: HCT Pharmacy Hospital

University of Technology and Applied Sciences – HCT PHARMACY
KEEP AWAY FROM CHILDREN ‫تحفظ بعيدا عن متناول األطفال‬

6 International Standards recommend the following information to appear in the la bel of dispensed medications:
- Patient Details (full name, Patient ID).
- Prescribers information (Name of institution, Reference number).
- Medicine Information (generic name, strength and dosage form, expiry date and batch number, Quantity dispensed).
- Main instructions on how to take/use the medication in English and Arabic with duration, Special cautionary/advisory instruct ions.
- Issue date (date of dispensing).

7 Use as many as required of labels for dispensing.

Departmental Pharmacy Training PHAR1200. © Department of Pharmacy 2020.